Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-01

Clinical Trial Update: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children [Phase 4]

View source ↗

Summary

Phase 4 study exploring optimal cetirizine dosing for allergic diseases in Chinese children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine (cetirizine)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Allergic Disease, Children | Phase 4 | Status: UNKNOWN